Despite therapeutic suppression of relapses, multiple sclerosis (MS) patients often
experience subtle deterioration, which extends beyond the definition of “progression …

Introduction While magnetic resonance imaging (MRI) is established in diagnosing and
monitoring disease activity in multiple sclerosis (MS), its utility in predicting and monitoring …

The preclinical phase of Alzheimer's disease represents a crucial time window for
therapeutic intervention but requires the identification of clinically relevant biomarkers that …

Abstract Background and Purpose Myoclonus dystonia due to a pathogenic variant in SGCE
(MYC/DYT‐SGCE) is a rare condition involving a motor phenotype associating myoclonus …

Background The traditional approach to studying the neurobiological mechanisms of brain
disorders and localizing brain function involves identifying brain abnormalities and …

Multiple sclerosis and aquaporin-4 antibody neuromyelitis optica spectrum disorders are
distinct autoimmune CNS disorders with overlap** clinical features but differing pathology …

We examined neurite orientation dispersion and density imaging in patients with migraine.
We found that patients with medication overuse headache exhibited lower orientation …

Background White matter hyperintensities (WMHs) might regress and progress
contemporaneously, but we know little about underlying mechanisms. We examined WMH …

Olfactory dysfunction (OD) is a non-motor symptom of Parkinson's Disease, affecting 75–
95% of the patients. This symptom usually emerges before the clinical diagnosis, and …

Rationale and Objectives Several quantitative magnetic resonance imaging (MRI) methods
are available to measure tissue injury in multiple sclerosis (MS), but their pathological …